NIH SBIR Grant application 1/5/2022

Mesa Science Associates has applied for an NIH Small Business Innovative Research (SBIR) Grant from the National Institutes of Health (NIH) for the Development of Cobinamide as a Novel Treatment for Aortic Aneurysms of Maran Syndrome. This grant would cover preliminary Pharmacokinetic studies to establish an optimal oral dose and whether maximal absorption occurs in the stomach or small intestine.  

MSA News

NIH SBIR Grant application 1/5/2022

Mesa Science Associates has applied for an NIH Small Business Innovative Research (SBIR) Grant from the National Institutes of Health…

Read More

Mesa Green Caine Study Results Reported at Epilepsy Conference

Mesa Science Associates Inc. (MSA) and Mesa Green Pharma LLC (MGP) are pleased to announce the results of a study…

Read More

Mesa Green Pharma LLC Receives Positive Feedback from FDA’s Center for Veterinary Medicine

Pilot Study Provides Positive Results for K9MGP Treatment Active Canine Seizures FREDERICK, Md. September 21,2021— Mr. Michael Mesa, CEO of…

Read More